-
Determinants of lenalidomide response with or without erythropoiesis-stimulating agents in myelodysplastic syndromes: the HOVON89 trial
van de Loosdrecht, A. A., Cremers, E. M. P., Alhan, C., Duetz, C., in ’t Hout, F. E. M., Visser-Wisselaar, H. A., Chitu, D. A., Verbrugge, A., Cunha, S. M., Ossenkoppele, G. J., Janssen, J. J. W. M., Klein, S. K., Vellenga, E., Huls, G. A., Muus, P., Langemeijer, S. M. C., de Greef, G. E., te Boekhorst, P. A. W., Raaijmakers, M. H. G. & van Marwijk Kooy, M. & 20 others, , Apr 2024, In: Leukemia. 38, 4, p. 840-850 11 p.Research output: Contribution to journal › Article* › Academic › peer-review
-
High-dose melphalan in 1 day versus over 2 days followed by autologous stem cell transplantation as consolidation treatment in patients with multiple myeloma
Aydin, M., Tang, M. W., Wondergem, M. J., de Leeuw, D. C., Wegman, J. J., Biemond, B. J., van de Donk, N. W. C. J., Zweegman, S., Meijer, E. & Nur, E., Mar 2022, In: British journal of haematology. 196, 6, p. e67-e70Research output: Contribution to journal › Comment/Letter to the editor* › Academic
-
MYD88 mutations identify a molecular subgroup of diffuse large B-cell lymphoma with an unfavorable prognosis
Vermaat, J. S., Somers, S. F., de Wreede, L. C., Kraan, W., de Groen, R. A. L., Schrader, A. M. R., Kerver, E. D., Scheepstra, C. G., Berenschot, H., Deenik, W., Wegman, J., Broers, R., de Boer, J.-P. D., Nijland, M., van Wezel, T., Veelken, H., Spaargaren, M., Cleven, A. H., Kersten, M. J. & Pals, S. T., 31 Jan 2020, In: Haematologica. 105, 2, p. 424-434 11 p.Research output: Contribution to journal › Article* › Academic › peer-review
- All publications
